Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Sirolimus and Glucocorticoids for the Maintenance of Remission in Patients With IgG4-related Disease

NCT05746689 is registered in ClinicalTrials.gov with Peking University International Hospital as lead sponsor.

NCT NCT05746689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Sirolimus and Glucocorticoids for the Maintenance of Remission in Patients With IgG4-related Disease
Lead sponsor
Peking University International Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2023
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

igg4-related disease